These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9434535)

  • 1. [Slowly progressive IDDM (SPIDDM)].
    Kobayashi T
    Nihon Rinsho; 1997 Nov; 55 Suppl():604-7. PubMed ID: 9434535
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of immunological markers in IDDM after more than 20 years from ICA description.
    Dotta F; Dionisi S; Farilla L; Di Mario U
    Diabetes Metab Rev; 1996 Jul; 12(2):121-6. PubMed ID: 8877281
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Slowly progressive insulin-dependent diabetes mellitus (SPIDDM)].
    Kobayashi T
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1152-4. PubMed ID: 12056010
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
    Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Islet cell antibody (ICA)].
    Kobayashi T
    Nihon Rinsho; 1997 Nov; 55 Suppl():328-32. PubMed ID: 9434489
    [No Abstract]   [Full Text] [Related]  

  • 7. [GAD antibody in IDDM].
    Yokota I; Shima K
    Rinsho Byori; 1998 Apr; 46(4):331-7. PubMed ID: 9594623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Slowly progressive IDDM (slowly progressive type 1 diabetes)].
    Kobayashi T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():413-7. PubMed ID: 12238082
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult.
    Beyan H; Ola T; David R; Leslie G
    Ann N Y Acad Sci; 2006 Oct; 1079():81-9. PubMed ID: 17130535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.
    Kobayashi T; Maruyama T; Shimada A; Kasuga A; Kanatsuka A; Takei I; Tanaka S; Yokoyama J
    Ann N Y Acad Sci; 2002 Apr; 958():117-30. PubMed ID: 12021091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical relevance of anti-GAD antibody in IDDM and NIDDM].
    Takahashi K; Satoh J; Toyota T
    Nihon Rinsho; 1997 Nov; 55 Suppl():319-23. PubMed ID: 9434487
    [No Abstract]   [Full Text] [Related]  

  • 14. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined antibody screening for improved prediction of IDDM--modern strategies.
    Roll U; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Slowly progressive IDDM (SPIDDM)].
    Kobayashi T; Kosaka K
    Nihon Rinsho; 1991 Feb; 49 Suppl():412-7. PubMed ID: 2033832
    [No Abstract]   [Full Text] [Related]  

  • 18. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS; Colman PG; Harrison LC
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention strategy of beta-cell failure in ICA-positive NIDDM].
    Kobayashi T
    Nihon Rinsho; 1997 Nov; 55 Suppl():765-8. PubMed ID: 9434561
    [No Abstract]   [Full Text] [Related]  

  • 20. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
    Martinka E; Ocenásová A; Straková J; Mokán M
    Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.